| Ticker Details |
CorMedix Inc.
Cormedix Inc is a commercial-stage biopharmaceutical company. It focuses on development and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases.
|
| IPO Date: |
May 13, 2010 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$508.98M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.14 | 4.06%
|
| Avg Daily Range (30 D): |
$0.15 | 2.01%
|
| Avg Daily Range (90 D): |
$0.24 | 2.49%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.4M |
| Avg Daily Volume (30 D): |
1.7M |
| Avg Daily Volume (90 D): |
2.61M |
| Trade Size |
| Avg Trade Size (Sh.): |
123 |
| Avg Trade Size (Sh.) (30 D): |
100 |
| Avg Trade Size (Sh.) (90 D): |
122 |
| Institutional Trades |
| Total Institutional Trades: |
924 |
| Avg Institutional Trade: |
$1.46M |
| Avg Institutional Trade (30 D): |
$1.39M |
| Avg Institutional Trade (90 D): |
$1.34M |
| Avg Institutional Trade Volume: |
.14M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.82M |
| Avg Closing Trade (30 D): |
$1.32M |
| Avg Closing Trade (90 D): |
$1.77M |
| Avg Closing Volume: |
188.34K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$2.25
|
$.13
|
$2.25
|
|
Diluted EPS
|
$2.04
|
$.07
|
$2.04
|
|
Revenue
|
$311.71M
|
$128.62M
|
$311.71M
|
|
Gross Profit
|
$275.75M
|
$107.31M
|
$275.75M
|
|
Net Income / Loss
|
$163.06M
|
$14.02M
|
$163.06M
|
|
Operating Income / Loss
|
$150.14M
|
$59.13M
|
$150.14M
|
|
Cost of Revenue
|
$22.09M
|
$11.17M
|
$22.09M
|
|
Net Cash Flow
|
$105.07M
|
$96.34M
|
$105.07M
|
|
PE Ratio
|
0.00
|
|
|
|
|
|
